0.2947
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
Detecting support and resistance levels for Intensity Therapeutics Inc.July 2025 Decliners & Smart Money Movement Alerts - Newser
Is now a turning point for Intensity Therapeutics Inc.Trade Exit Summary & Free Safe Entry Trade Signal Reports - Newser
Using Python tools to backtest Intensity Therapeutics Inc. strategiesMarket Performance Report & Growth Focused Investment Plans - Newser
How Resilient Is Intensity Therapeutics Inc. Stock During Economic DownturnsJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Intensity (INTS) Q2 Net Loss Drops 50% - AOL.com
Intensity Therapeutics regains Nasdaq compliance - MSN
Can a trend reversal in Intensity Therapeutics Inc. lead to recoveryJuly 2025 Sector Moves & Growth Focused Stock Reports - Newser
Analyzing recovery setups for Intensity Therapeutics Inc. investors2025 Risk Factors & Daily Chart Pattern Signals - Newser
Intensity Therapeutics Reports Reduced Losses and Clinical Progress - TipRanks
Using data filters to optimize entry into Intensity Therapeutics Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
Intensity Therapeutics Inc (INTS) Stock: Navigating a Year of Volatility - investchronicle.com
Shelton-based biotech regains Nasdaq compliance - Hartford Business Journal
Intensity Therapeutics Amends Bylaws for Quorum Change - MSN
Sentiment analysis tools applied to Intensity Therapeutics Inc.Free Triple Digit Return Stock Predictions - Newser
Can momentum traders help lift Intensity Therapeutics Inc.New Guidance & Real-Time Market Trend Scan - Newser
How to recover losses in Intensity Therapeutics Inc. stock [2025 Pullback Review]Free Community Trade Idea Sharing Platform - Newser
Brookline Capital upgrades Intensity Therapeutics stock rating to Buy By Investing.com - Investing.com Australia
Brookline Capital upgrades Intensity Therapeutics stock rating to Buy - Investing.com
Intensity Therapeutics regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria
Intensity Therapeutics regains compliance with Nasdaq listing requirements - Investing.com
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - WV News
Intensity Therapeutics shares fall 2.96% premarket as health care sector sees mixed performance. - AInvest
How Intensity Therapeutics Inc. stock performs during market volatilityFree Stock Market Watch With Alerts - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionBuy and Hold Position Summary Review - Newser
Multi factor analysis applied to Intensity Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser
Is Intensity Therapeutics Inc. still worth holding after the dipStock Portfolio Risk and Return Analysis - Newser
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Morningstar
Is Intensity Therapeutics Inc. meeting your algorithmic filter criteriaTechnical Insight Guide for Safer Trades - Newser
Intensity Therapeutics Secures $11.3M Funding as Cancer Drug Shows 8-Day Tumor Response in Clinical Trial - Stock Titan
Shelton biotech raises millions for novel cancer treatment - Hartford Business Journal
How to recover losses in Intensity Therapeutics Inc. stockLow Risk Strategy with Smart Entry Zones - Newser
Intensity Therapeutics shares rise 2.26% premarket after raising $6.6 million in gross proceeds. - AInvest
why intensity therapeutics inc. stock attracts strong analyst attentionAI-Based Reversal Point Prediction Signal - Newser
Intensity Therapeutics Raises $6.6 Million in July Offering - TipRanks
Intensity Therapeutics Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Intensity Therapeutics raises $6.6M from ATM stock sales in July - TipRanks
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025 - Citizen Tribune
Biotech Intensity Therapeutics Secures $6.6M Funding at Premium Price, Extends Operations Through 2026 - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):